Sweet itch (Insect Bite Hypersensitivity, IBH) is a chronic, intensely pruritic allergic skin disease caused by hypersensitivity to the bites of Culicoides midges. It is one of the most common and welfare-significant skin conditions in horses and ponies, causing year-round suffering in severely affected animals during midge season.
Sweet itch develops through a Type I (IgE-mediated) and Type IV (T-cell mediated) hypersensitivity reaction to antigens in Culicoides saliva. Not all horses are hypersensitive—a genetic predisposition exists, with higher prevalence in certain breeds (particularly native ponies, Icelandic horses, and Friesians) and family lines. First sensitisation typically occurs in the first 2-3 years of life, with clinical severity often worsening over subsequent seasons as hypersensitivity intensifies.
Affected horses show intense pruritus (itching), leading to: vigorous rubbing of mane, tail head, face, and belly against any available surface; self-induced alopecia (hair loss) and skin trauma; thickening and lichenification (hardening) of skin in chronic cases; sleeplessness and constant movement to escape biting; and secondary bacterial infections of damaged skin. In severely affected animals, welfare is profoundly compromised throughout the midge season (spring to autumn in the UK). Horses may be unable to rest normally, continually preoccupied with itching.
Prevention of Culicoides bites is the most effective management strategy. Culicoides are most active at dawn and dusk, in warm, still conditions. Management includes: stabling at dawn and dusk during peak midge activity, using fine-mesh fly rugs and hoods specifically designed for sweet itch (covering affected areas), applying insect repellent products (permethrin, citronella-based), and avoiding turnout near standing water (midge breeding sites). Fans in stables can deter midges. No single method provides complete protection in severely affected animals.
Corticosteroids (dexamethasone, prednisolone) provide relief from pruritus but carry risks with long-term use (laminitis risk in susceptible horses, immunosuppression). Short courses during severe flare-ups may be appropriate. Antihistamines have limited efficacy in horses compared to small animals. Novel approaches including Janus kinase inhibitors (used in dogs with atopic dermatitis) are being investigated for horses. Topical soothing preparations (medicated shampoos, emollient creams) provide symptomatic relief.
Allergen-specific immunotherapy (desensitisation) using Culicoides antigen extracts is available for horses. As in other species, immunotherapy aims to modify the immune response to reduce hypersensitivity over time. Results are variable—some horses show significant improvement over 2-3 years of treatment, others respond poorly. Immunotherapy requires commitment and correct diagnosis before initiation.
Sweet itch has strong heritability, so affected animals should not be used for breeding to prevent perpetuating the condition. Breed registries and welfare organisations advise against breeding from severely affected animals. This welfare consideration should be discussed sensitively with owners, particularly for valuable breeding stock.